|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 110.40 USD | -1.04% |
|
-1.81% | +64.04% |
| 09-30 | Halozyme Therapeutics, Inc. Appoints James "Jim" Daly to Its Board of Directors | CI |
| 09-18 | Halozyme Prices $1.3 Billion Convertible Senior Notes Offering | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.04% | -1.81% | +3.67% | +41.05% | +64.04% | +50.53% | +189.01% | +171.39% | +813.91% | 12.53B | |
| -2.33% | +0.53% | +0.03% | -3.53% | +7.67% | +51.65% | +115.42% | +400.79% | +1,341.66% | 1,031B | |
| -1.06% | -1.65% | -0.42% | +4.24% | +27.92% | +42.78% | +69.98% | +63.93% | +124.11% | 638B | |
| -0.65% | -1.32% | +2.02% | +3.95% | +14.49% | +12.98% | +75.49% | +142.50% | +314.76% | 462B | |
| -2.66% | -1.87% | -1.66% | +13.08% | +38.05% | +73.13% | +41.15% | +93.46% | +132.83% | 359B | |
| +0.77% | -3.16% | +1.27% | +7.03% | +7.22% | +24.65% | +41.87% | +1.93% | +45.59% | 335B | |
| -0.53% | +0.08% | -9.09% | -4.75% | +8.63% | +14.46% | +27.51% | +56.53% | +54.82% | 273B | |
| -0.96% | -1.97% | +1.62% | -12.26% | -11.85% | -2.25% | +11.01% | +38.56% | +141.14% | 253B | |
| -0.50% | +3.80% | -1.95% | +16.40% | +28.78% | +49.37% | +56.84% | +98.22% | +152.69% | 228B | |
| -1.47% | -1.53% | +1.85% | +17.98% | +21.44% | +34.28% | +98.89% | +113.39% | +88.38% | 185B | |
| -0.48% | -0.87% | -14.66% | -22.59% | -22.89% | -31.58% | -60.62% | -18.17% | +84.75% | 170B | |
| -0.70% | +1.21% | +0.21% | +18.44% | +14.54% | +11.93% | -14.02% | -33.69% | -15.80% | 163B | |
| -0.74% | +1.25% | -3.99% | +5.25% | +15.32% | +33.49% | +50.35% | +188.22% | +499.48% | 133B | |
| -0.73% | +2.04% | -6.60% | +8.30% | +15.68% | +38.36% | +7.51% | +5.46% | +15.73% | 127B | |
| -1.27% | -3.03% | -3.56% | +13.00% | +4.09% | +10.52% | +96.35% | +328.23% | +412.03% | 99.55B | |
| -0.23% | -2.61% | -2.32% | -5.28% | +0.19% | +9.36% | +23.18% | +5.54% | -12.17% | 97.46B | |
| +2.55% | +3.37% | -3.03% | +2.03% | -9.90% | -12.50% | -26.80% | -9.78% | +9.22% | 98.83B | |
| -5.35% | +5.74% | +37.22% | +174.98% | +553.00% | +645.53% | +86.44% | -49.96% | - | 76.88B | |
| +1.03% | -5.43% | -5.11% | +21.61% | -1.76% | +34.86% | -7.86% | +25.30% | +88.61% | 75.72B | |
| -0.92% | +2.05% | -2.18% | -5.40% | +11.50% | +13.49% | -11.52% | -25.30% | +41.73% | 68.18B | |
| Average | +0.07% | -0.11% | -0.33% | +14.68% | +39.31% | +55.25% | +43.51% | +79.83% | +228.08% | 244.28B | |
| Weighted average by Cap. | +0.44% | -0.15% | -0.82% | +5.67% | +21.34% | +41.44% | +57.46% | +137.24% | +397.95% |
- Stock Market
- Stocks
- HALO Stock
- Sector Halozyme Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
